Black Diamond Financial, LLC Catalyst Biosciences, Inc. Transaction History

Black Diamond Financial, LLC

  • $587 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$0.91 - $4.16 $21,840 - $99,840
-24,000 Reduced 57.14%
18,000 $16,000
Q2 2021

Jul 27, 2021
BUY
$4.1 - $5.33 $16,400 - $21,320
4,000 Added 10.53%
42,000 $182,000
Q1 2021

May 03, 2021
BUY
$4.93 - $7.15 $187,340 - $271,700
38,000 New
38,000 $192,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Black Diamond Financial, LLC Portfolio

Follow Black Diamond Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Diamond Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Black Diamond Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email